Feasibility and utility of synthetic control arms derived from real-world data to support clinical development.

Authors

null

Jaclyn Paige Lyman

Parker Institute for Cancer Immunotherapy, San Francisco, CA

Jaclyn Paige Lyman , Abigail Doucette , Binbin Zheng-Lin , Christopher R. Cabanski , Molly A. Maloy , Nicholas L. Bayless , Jingying Xu , William Smith , Joyson Joseph Karakunnel , Justin P. Fairchild , Ramy Ibrahim , Eileen Mary O'Reilly , Robert H. Vonderheide , Peter Edward Gabriel

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

DOI

10.1200/JCO.2022.40.4_suppl.528

Abstract #

528

Poster Bd #

E10

Abstract Disclosures